Davis's Drug Guide
source

Davis's Drug Guide

(672)
Price
Free
Category
Medical
Last update
Jul 08, 2021
Publisher
Unbound Medicine, Inc Contact publisher
Loading...

Ratings & Reviews performance

Ratings & Reviews performance provides an overview of what users think of your app. Here are the key metrics to help you identify how your app is rated by users and how successful is your review management strategy.

Number of reviews,
total
672
Avg rating,
total
⭐4.7
Loading...

Description

2808 chars

- FREE 30-DAY TRIAL - NEW 17th edition content with over 600 new and revised monographs. Try the integrated calculators, view pill images, listen to audio pronunciations, and get exclusive access to official drugguide.com FREE for 30 days. DRUG GUIDE FEATURES: • 1,700+ monographs — covering 5000+ trade name and generic drugs • Audio pronunciations — to learn new drug names • Pill images — to visually confirm drug forms • Regular updates — featuring new FDA approvals and prescribing changes • Critical safety alerts and warnings • Highlighted Risk Evaluation and Mitigation Strategies (REMS) EXCLUSIVE UNBOUND FEATURES • Key IV and dosing calculators — fully integrated • Highlighting and note-taking within entries • “Favorites” for bookmarking important entries • Enhanced Search to find medications quickly • Access to the official DrugGuide.com website 30-DAY TRIAL: WHAT TO EXPECT • First-time users can access Unbound's complete Davis’s Drug Guide mobile app free for 30 days • After 30 days, your Google Play account will be charged $39.99 for a one-year subscription unless you have turned off auto-renew at least 24 hours before the free trial ends. • To manage your subscriptions, open the Google Play Store. Check if you're signed in to the correct Google Account. Tap Menu Subscriptions, then select the subscription you want to modify. Follow the instructions on the screen to pause, cancel, or change your subscription. • NOTE: When you cancel a subscription you’ll still be able to use your subscription for the time you’ve already paid. If you do choose not to purchase a subscription, the content will no longer be viewable after the free-trial period ends. DRUG INTERACTIONS UPGRADE OPTION: Add Drug Interactions from The Medical Letter to your Davis’s Drug Guide app. Once your Davis Drug Guide paid subscription is active, you can easily add a 1-year subscription to Drug Interactions -- the most trusted drug interaction checker available. • Initial purchase includes a 1-year subscription with regular content updates. • Your subscription will automatically renew annually, and your Google Play account will be charged the renewal rate of $34.99 unless auto-renew is turned off 24 hours before the conclusion of the one-year subscription period. • If you do not choose to renew, you can continue to use the product but will not receive content updates. • To manage your subscriptions, open the Google Play Store. Check if you're signed in to the correct Google Account. Tap Menu Subscriptions, then select the subscription you want to modify. Follow the instructions on the screen to pause, cancel, or change your subscription. Authors: April Hazard Vallerand, PhD, RN, FAAN; Cynthia A. Sanoski, BS, PharmD, FCCP, BCPS Publisher: F.A. Davis Powered by: Unbound Medicine

Screenshots

https://play-lh.googleusercontent.com/7cTYqYPEaKWIRaNKhgAS2UZ3xsMMcioNbqxH689V62WuQ86jT37NJzJLQ2-Z0xeFQP0=w720-h310https://play-lh.googleusercontent.com/ZtktCtdCPNYWhVcXmbHRIDo3hDAWXVwbXLiAqOdZKJrnT8dldrOKv2IaBvvZXpsBCEc=w720-h310https://play-lh.googleusercontent.com/jA18fliNENIaKRQ3c9zvWSaK2jcWvjc9Kw62RZ46aZyH1vwq_qaI_hQuNKC8i7U01P4=w720-h310https://play-lh.googleusercontent.com/hu16WF6aUdd8FHAJ930EkBJvFhv0aYSGuGwJSYIxJ-3Cje6B3Y45zTuiDxRDyD9ly4M=w720-h310https://play-lh.googleusercontent.com/xy8zqCSxxgHuTnURt5RlIZd8k1BCwU7V1GhVYWFxwGoWOQ-RsXqZhtCqnP8F_SkGfec=w720-h310https://play-lh.googleusercontent.com/PY-3Kz1r3HdBKIzqav82-13nsZQr5FrSCUWob4C3PsFaa3uCzfDoOxDjPA0eKuDnrjpT=w720-h310https://play-lh.googleusercontent.com/oFYwcTgrXioiX7i2qiMaC56vOXTeFDmYYvQP9YcKGgANlPrYlPcVwJCCdy38ZwIDQjA=w720-h310https://play-lh.googleusercontent.com/J57VKsL2pDQ6WK3rM2zdakFjaDS24DYn1RK6aTEOSEEEX4s1aEJzRoENLLxoWzM-ECtb=w720-h310https://play-lh.googleusercontent.com/vZuTeolqSo0Z1DhtB-zTFyD9Lc5IX3G1gHKgY8zdoa_fRZuEtCoJQOJbuEZZObX7ZWk=w720-h310https://play-lh.googleusercontent.com/0TCOqS0n-66GdJylcejuySZ9lc0ncw5Y7qxC-xZrF6WVsmtxwQI9RMy8WaXJPLq8Wtvc=w720-h310https://play-lh.googleusercontent.com/1POPdLYiIz6a8m5lnwjWChgzuEcYpC2u0SfwxZdsQ1l5mKwUSMja_x3X-OMMV1xrhiP9=w720-h310https://play-lh.googleusercontent.com/7E1CazGkE5tAt8BlTyo395B96Blm7ryTtAR96laX2tthxe4zuZQ1gkHTw-u6pB9ZioY=w720-h310https://play-lh.googleusercontent.com/4j_toS7BoXCCOQ4tbJeV5AEFyYQrEx3bim5xiQKjia-vLq_VUbRqidyRRktgXErVetM=w720-h310https://play-lh.googleusercontent.com/_vDjCSWTVBNC8uf7caj-V-Qhxe8-T2xGyfobLuzOIlgwk-G2L4zVifmSlxXuUjNjedI=w720-h310https://play-lh.googleusercontent.com/BHf0-qVGyx2RwsYP72I8Ziqzl39N68AthWiXxwmcn5C-JdZYISX3PYXBsIyDkZeHMYE=w720-h310https://play-lh.googleusercontent.com/A2u3AeI5FZUs8NedHu7igcWPtScGERhlclFdVaL4jDRUX4gchYsCAxovnv0S085kEfs=w720-h310https://play-lh.googleusercontent.com/_6RXByMwS8Gu7BLMrChJvUbzUsYwB-4sQHsFEEHIVHrsnOaCg5mgQDAnfNegVT3gV_XN=w720-h310https://play-lh.googleusercontent.com/uanvc3j8-A4N3_wcoSVwJh_TV9eLXcppk_9oontzSBFRFm9kNyDeZxYSidvJESGMPNU=w720-h310https://play-lh.googleusercontent.com/UaICIfjYRE1n7TGjS5V_OHHVQ_MjUsuQEcsWzDqUwndIj-QCRoR6F8xPjTOvPZAJgwc=w720-h310https://play-lh.googleusercontent.com/nuAJtPbAyEebXAY5idSyPrSTMMqjzGRYFezFR-yQX86A6QxY-omoioGlBlpEwU4kxohi=w720-h310
Loading...
Loading...

Find growth insights on our blog

React to user feedback and market trends faster